vs
Side-by-side financial comparison of SolarMax Technology, Inc. (SMXT) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $46.6M, roughly 1.0× SolarMax Technology, Inc.). SolarMax Technology, Inc. runs the higher net margin — -1.9% vs -33.9%, a 32.0% gap on every dollar of revenue. On growth, SolarMax Technology, Inc. posted the faster year-over-year revenue change (623.5% vs -15.6%).
SolarMax Technology, Inc. develops, manufactures and sells high-efficiency solar PV modules and clean energy systems. It serves residential, commercial and industrial clients in North America and key Asia-Pacific markets, offering installation and after-sales support to boost low-carbon energy use.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
SMXT vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $46.6M | $47.1M |
| Net Profit | $-872.2K | $-16.0M |
| Gross Margin | 2.7% | 48.9% |
| Operating Margin | -2.7% | -17.7% |
| Net Margin | -1.9% | -33.9% |
| Revenue YoY | 623.5% | -15.6% |
| Net Profit YoY | 77.7% | 68.8% |
| EPS (diluted) | $-0.02 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $46.6M | $47.1M | ||
| Q3 25 | $30.6M | $38.2M | ||
| Q2 25 | $6.9M | $38.4M | ||
| Q1 25 | $6.9M | $32.5M | ||
| Q4 24 | $6.4M | $55.8M | ||
| Q3 24 | $6.3M | $29.3M | ||
| Q2 24 | — | $34.0M | ||
| Q1 24 | — | $25.5M |
| Q4 25 | $-872.2K | $-16.0M | ||
| Q3 25 | $-2.3M | $-23.8M | ||
| Q2 25 | $-1.9M | $202.5M | ||
| Q1 25 | $-1.3M | $-25.0M | ||
| Q4 24 | $-3.9M | $-51.1M | ||
| Q3 24 | $-9.6M | $-148.3M | ||
| Q2 24 | — | $-582.3M | ||
| Q1 24 | — | $-72.3M |
| Q4 25 | 2.7% | 48.9% | ||
| Q3 25 | 3.1% | 35.5% | ||
| Q2 25 | 8.8% | 33.4% | ||
| Q1 25 | 20.5% | 32.4% | ||
| Q4 24 | 14.5% | -4.4% | ||
| Q3 24 | 19.9% | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | -2.7% | -17.7% | ||
| Q3 25 | -6.9% | -33.6% | ||
| Q2 25 | -25.7% | -34.8% | ||
| Q1 25 | -16.7% | -65.0% | ||
| Q4 24 | -27.9% | -84.4% | ||
| Q3 24 | -158.4% | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | — | -267.0% |
| Q4 25 | -1.9% | -33.9% | ||
| Q3 25 | -7.4% | -62.2% | ||
| Q2 25 | -27.6% | 527.8% | ||
| Q1 25 | -18.7% | -76.9% | ||
| Q4 24 | -60.6% | -91.6% | ||
| Q3 24 | -152.0% | -506.3% | ||
| Q2 24 | — | -1712.6% | ||
| Q1 24 | — | -283.9% |
| Q4 25 | $-0.02 | $-4.40 | ||
| Q3 25 | $-0.04 | $-2.84 | ||
| Q2 25 | $-0.04 | $-1.79 | ||
| Q1 25 | $-0.03 | $-0.15 | ||
| Q4 24 | $-0.07 | $-15.29 | ||
| Q3 24 | $-0.21 | $-18.24 | ||
| Q2 24 | — | $-71.81 | ||
| Q1 24 | — | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.0M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-12.2M | $-249.4M |
| Total Assets | $91.3M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.0M | $48.9M | ||
| Q3 25 | $5.7M | $43.1M | ||
| Q2 25 | $1.9M | $40.8M | ||
| Q1 25 | $6.8M | $58.6M | ||
| Q4 24 | $7.1M | $56.3M | ||
| Q3 24 | $8.6M | $75.4M | ||
| Q2 24 | — | $89.6M | ||
| Q1 24 | — | $112.8M |
| Q4 25 | $-12.2M | $-249.4M | ||
| Q3 25 | $-11.8M | $-235.7M | ||
| Q2 25 | $-15.1M | $-214.1M | ||
| Q1 25 | $-15.9M | $-417.5M | ||
| Q4 24 | $-15.1M | $-398.4M | ||
| Q3 24 | $-10.9M | $-344.1M | ||
| Q2 24 | — | $-203.2M | ||
| Q1 24 | — | $371.6M |
| Q4 25 | $91.3M | $308.9M | ||
| Q3 25 | $58.7M | $362.6M | ||
| Q2 25 | $38.2M | $379.2M | ||
| Q1 25 | $38.6M | $405.1M | ||
| Q4 24 | $38.6M | $437.4M | ||
| Q3 24 | $43.0M | $537.8M | ||
| Q2 24 | — | $691.5M | ||
| Q1 24 | — | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $8.2M | ||
| Q3 25 | $3.4M | $11.4M | ||
| Q2 25 | $220.7K | $-21.3M | ||
| Q1 25 | $-601.1K | $8.5M | ||
| Q4 24 | $-1.3M | $-14.7M | ||
| Q3 24 | $203.6K | $-9.4M | ||
| Q2 24 | — | $-11.9M | ||
| Q1 24 | — | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SMXT
| Yabucoa | $35.9M | 77% |
| Other | $10.7M | 23% |
STEM
Segment breakdown not available.
